• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年新冠病毒肺炎患者的免疫学特征:新冠后时代分析

Immunological characteristics in elderly COVID-19 patients: a post-COVID era analysis.

作者信息

Li Yunhui, Chen Yuan, Liang Jing, Wang Yajie

机构信息

Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

出版信息

Front Cell Infect Microbiol. 2024 Nov 29;14:1450196. doi: 10.3389/fcimb.2024.1450196. eCollection 2024.

DOI:10.3389/fcimb.2024.1450196
PMID:39679195
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11638707/
Abstract

BACKGROUND

Advanced age is a primary risk factor for adverse COVID-19 outcomes, potentially attributed to immunosenescence and dysregulated inflammatory responses. In the post-pandemic era, with containment measures lifted, the elderly remain particularly susceptible, highlighting the need for intensified focus on immune health management.

METHODS

A total of 281 elderly patients were enrolled in this study and categorized based on their clinical status at the time of admission into three groups: non-severe (n = 212), severe survivors (n = 49), and severe non-survivors (n = 20). Binary logistic regression analysis was employed to identify independent risk factors associated with disease severity and in-hospital outcomes. The diagnostic performance of risk factors was assessed using the receiver operating characteristic (ROC) curves. Kaplan-Meier survival analysis and log-rank test were utilized to compare the 30-day survival rates. Furthermore, the transcriptomic data of CD4 T cells were extracted from Gene Expression Omnibus (GEO) database. Gene Set Enrichment Analysis (GSEA) was applied to reveal biological processes and pathways involved.

RESULTS

In the comparison between severe and non-severe COVID-19 cases, significant elevations were observed in the neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), and Serum Amyloid A (SAA) levels, concurrent with a notable reduction in CD8 T cells, CD4 T cells, natural killer (NK) cells, and monocytes (all < 0.05). CD4 T cells (OR: 0.997 [0.995-1.000], <0.05) and NLR (OR: 1.03 [1.001-1.060], <0.05) were independent risk factors affecting disease severity. The diagnostic accuracy for COVID-19 severity, as measured by the area under the curve (AUC) for CD4 T cells and NLR, was 0.715 (95% CI: 0.645-0.784) and 0.741 (95% CI: 0.675-0.807), respectively. Moreover, patients with elevated NLR or IL-6 levels at admission exhibited significantly shorter survival times. Gene Set Enrichment Analysis (GSEA) revealed several biological pathways that are implicated in the regulation of immune responses and metabolic processes.

CONCLUSIONS

Lymphocytopenia and the cytokine storm onset are significant predictors of an unfavorable prognosis in elderly patients. The decrease in CD4 T cells among elderly patients is detrimental to disease recovery, and the biological pathways regulated by these cells could potentially heighten vulnerability to SARS-CoV-2 infection, thereby exacerbating the development of associated complications.

摘要

背景

高龄是新冠病毒病(COVID-19)不良结局的主要危险因素,这可能归因于免疫衰老和炎症反应失调。在疫情后时代,随着防控措施的解除,老年人仍然特别易感,这凸显了加强免疫健康管理的必要性。

方法

本研究共纳入281例老年患者,并根据入院时的临床状态将其分为三组:非重症组(n = 212)、重症存活组(n = 49)和重症非存活组(n = 20)。采用二元逻辑回归分析来确定与疾病严重程度和院内结局相关的独立危险因素。使用受试者工作特征(ROC)曲线评估危险因素的诊断性能。采用Kaplan-Meier生存分析和对数秩检验比较30天生存率。此外,从基因表达综合数据库(GEO)中提取CD4 T细胞的转录组数据。应用基因集富集分析(GSEA)来揭示所涉及的生物学过程和通路。

结果

在重症与非重症COVID-19病例的比较中,中性粒细胞与淋巴细胞比值(NLR)、C反应蛋白(CRP)和血清淀粉样蛋白A(SAA)水平显著升高,同时CD8 T细胞、CD4 T细胞、自然杀伤(NK)细胞和单核细胞显著减少(均P<0.05)。CD4 T细胞(比值比:0.997[0.9951.000],P<0.05)和NLR(比值比:1.03[1.0011.060],P<0.05)是影响疾病严重程度的独立危险因素。以CD4 T细胞和NLR的曲线下面积(AUC)衡量的COVID-19严重程度的诊断准确性分别为0.715(95%置信区间:0.6450.784)和0.741(95%置信区间:0.6750.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad09/11638707/7321903ada86/fcimb-14-1450196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad09/11638707/b23f6e97bc54/fcimb-14-1450196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad09/11638707/b7336f9d0536/fcimb-14-1450196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad09/11638707/7321903ada86/fcimb-14-1450196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad09/11638707/b23f6e97bc54/fcimb-14-1450196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad09/11638707/b7336f9d0536/fcimb-14-1450196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad09/11638707/7321903ada86/fcimb-14-1450196-g003.jpg

相似文献

1
Immunological characteristics in elderly COVID-19 patients: a post-COVID era analysis.老年新冠病毒肺炎患者的免疫学特征:新冠后时代分析
Front Cell Infect Microbiol. 2024 Nov 29;14:1450196. doi: 10.3389/fcimb.2024.1450196. eCollection 2024.
2
Abnormal immunity of non-survivors with COVID-19: predictors for mortality.COVID-19 非幸存者的异常免疫:死亡预测因子。
Infect Dis Poverty. 2020 Aug 3;9(1):108. doi: 10.1186/s40249-020-00723-1.
3
CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.CD4 和 CD8 淋巴细胞计数作为 SARS-CoV-2 肺炎进展的替代早期标志物:一项前瞻性研究。
Viruses. 2020 Nov 9;12(11):1277. doi: 10.3390/v12111277.
4
Study on the predictive value of laboratory inflammatory markers and blood count-derived inflammatory markers for disease severity and prognosis in COVID-19 patients: a study conducted at a university-affiliated infectious disease hospital.研究实验室炎症标志物和基于血常规的炎症标志物对 COVID-19 患者疾病严重程度和预后的预测价值:在一家大学附属医院传染病医院进行的研究。
Ann Med. 2024 Dec;56(1):2415401. doi: 10.1080/07853890.2024.2415401. Epub 2024 Oct 24.
5
[Value of interleukin-6 and CD4 T-lymphocytopenia in assessing the severity and prognosis of coronavirus disease 2019].[白细胞介素-6及CD4 T淋巴细胞减少在评估2019冠状病毒病严重程度及预后中的价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Oct;32(10):1165-1170. doi: 10.3760/cma.j.cn121430-20200521-00395.
6
Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).中性粒细胞与淋巴细胞比值和 C 反应蛋白水平对 2019 冠状病毒病(COVID-19)的应用价值。
Scand J Clin Lab Invest. 2020 Nov;80(7):536-540. doi: 10.1080/00365513.2020.1803587. Epub 2020 Aug 17.
7
Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths.COVID-19 死亡 85 例的临床特征及外周免疫细胞亚群改变。
Aging (Albany NY). 2021 Mar 12;13(5):6289-6297. doi: 10.18632/aging.202819.
8
Immune dysfunction following COVID-19, especially in severe patients.新冠病毒感染后免疫功能障碍,尤其是在重症患者中。
Sci Rep. 2020 Sep 28;10(1):15838. doi: 10.1038/s41598-020-72718-9.
9
COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.新型冠状病毒肺炎(COVID-19)与癌症:临床免疫指标差异的发现。
J Immunol Res. 2021 Oct 18;2021:8669098. doi: 10.1155/2021/8669098. eCollection 2021.
10
Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.COVID-19 相关的低生存率与淋巴细胞减少和更高的中性粒细胞与淋巴细胞比值相关。
Isr Med Assoc J. 2021 Mar;23(3):153-159.

本文引用的文献

1
Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia.接种疫苗和未接种疫苗的老年 COVID-19 肺炎患者的免疫特征。
J Transl Med. 2024 Aug 12;22(1):755. doi: 10.1186/s12967-024-05556-2.
2
Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people.英格兰地区 2019 冠状病毒病(COVID-19)大流行期间感染 SARS-CoV-2 后发生糖尿病的发病率:一项涉及 1600 万人的回顾性队列研究。
Lancet Diabetes Endocrinol. 2024 Aug;12(8):558-568. doi: 10.1016/S2213-8587(24)00159-1.
3
The immune inflammation factors associated with disease severity and poor prognosis in patients with COVID-19: A retrospective cohort study.
与新型冠状病毒肺炎患者疾病严重程度及不良预后相关的免疫炎症因子:一项回顾性队列研究
Heliyon. 2023 Dec 12;10(1):e23583. doi: 10.1016/j.heliyon.2023.e23583. eCollection 2024 Jan 15.
4
Covid-19: WHO adds JN.1 as new variant of interest.新冠病毒:世界卫生组织将JN.1列为新的关注变异株。
BMJ. 2023 Dec 21;383:2975. doi: 10.1136/bmj.p2975.
5
Diabetes Mellitus, Energy Metabolism, and COVID-19.糖尿病、能量代谢与 COVID-19
Endocr Rev. 2024 Mar 4;45(2):281-308. doi: 10.1210/endrev/bnad032.
6
Humoral immune response characteristics of the elderly, children and pregnant women after XBB infection.XBB感染后老年人、儿童和孕妇的体液免疫反应特征
J Infect. 2023 Dec;87(6):e96-e99. doi: 10.1016/j.jinf.2023.10.006. Epub 2023 Oct 14.
7
Excess All-Cause Mortality in China After Ending the Zero COVID Policy.中国取消“动态清零”政策后全因死亡率的变化。
JAMA Netw Open. 2023 Aug 1;6(8):e2330877. doi: 10.1001/jamanetworkopen.2023.30877.
8
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial.COVID-19 患者中 JAK1/2 抑制剂芦可替尼引发的过度炎症:RuxCoFlam 试验。
Leukemia. 2023 Sep;37(9):1879-1886. doi: 10.1038/s41375-023-01979-w. Epub 2023 Jul 28.
9
C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps.C5aR1 信号通过中性粒细胞胞外诱捕网触发 COVID-19 肺部免疫病理学。
J Clin Invest. 2023 Jun 15;133(12):e163105. doi: 10.1172/JCI163105.
10
Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.2022 年北京地区 SARS-CoV-2 变异株的特征:一项流行病学和系统进化分析。
Lancet. 2023 Feb 25;401(10377):664-672. doi: 10.1016/S0140-6736(23)00129-0. Epub 2023 Feb 8.